A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)
Having severe anorexia nervosa (AN) (DSM-IV-R) for \> 12 months before screening
Presenting with very low bone mineral density (defined as Z-Score \< -2.5 or T-Score \< -2.5 if available) of at least one of the assessed localizations (lumbar spine L1 - L4, total hip, femoral neck) without any previous fragility fracture
or low bone mineral density (defined as Z-Score \< -1.5 or T-Score \< -1.5 if available) of at least one of the assessed localizations (lumbar spine L1 - L4, total hip, femoral neck) and at least one previous fragility fracture
In- and out-patients of the Centre for Eating Disorders at the Clinic for Psychiatry and Psychotherapy of the University Hospital of Zurich.
You may not be if
Incapacity to understand the aims of the study or patients not willing to collaborate.
